A Randomized Trial of Bevacizumab for Newly Diagnosed GlioblastomaMark R. Gilbert, Minesh P. Mehta, Kurt A. Jaeckle et al.|New England Journal of Medicine|2014Cited by 2.8k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical TrialMark R. Gilbert, Minesh P. Mehta, Meihua Wang et al.|Journal of Clinical Oncology|2013Cited by 1.1k
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialPaul D. Brown, S. Pugh, Nadia N. Laack et al.|Neuro-Oncology|2013Cited by 942
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D. Brown, Vinai Gondi, Stephanie L. Pugh et al.|Journal of Clinical Oncology|2020Cited by 827
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancerJeffrey S. Wefel, Christina A. Meyers|Cancer|2010Cited by 508